Vir Biotechnology Overview
Vir Biotechnology Target Price
Analysts' 12-month price predictions for VIR.
Get informed when a big investor buys or sells
+ FollowShare Price
$10.04
Average Target Price
$23.33
132.4% upside
132.4% upside3 analysts in the last 4 months
High: $27 | Low: $20
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-11 | Morgan Stanley | $27 | 168.9% upside |  |
| 2026-05-08 | Morgan Stanley | $23 | 129.1% upside | |
| 2026-03-04 | H.C. WainwrightPatrick Trucchio | $20 | 99.2% upside | |
| 2026-02-26 | Leerink PartnersRoanna Ruiz | $20 | 99.2% upside | |
| 2026-02-24 | Barclays | $30 | 198.8% upside | |
| 2026-02-24 | Evercore ISICory Kasimov | $18 | 79.3% upside | |
| 2026-02-24 | NeedhamJoseph Stringer | $18 | 79.3% upside | |
| 2026-02-24 | Morgan StanleyMichael Ulz | $24 | 139% upside | |
| 2026-02-24 | Raymond JamesSean McCutcheon | $19 | 89.2% upside | |
| 2026-02-17 | Barclays | $26 | 159% upside | |
| 2026-02-04 | BarclaysEtzer Darout | $24 | 139% upside | |
| 2025-12-30 | H.C. WainwrightPatrick Trucchio | $15 | 49.4% upside | |
| 2025-07-11 | Raymond JamesSean McCutcheon | $12 | 19.5% upside | |
| 2025-01-09 | Morgan StanleyMichael Ulz | $20 | 99.2% upside | |
| 2024-08-02 | BarclaysGena Wang | $28 | 178.9% upside | |
| 2024-06-05 | Morgan StanleyMichael Ulz | $15 | 49.4% upside | |
| 2024-05-21 | BarclaysGena Wang | $27 | 168.9% upside | |
| 2023-02-21 | Goldman SachsPaul Choi | $28.38 | 182.7% upside | |
| 2022-05-06 | NeedhamJoseph Stringer | $35 | 248.6% upside | |